BCL2 and osteosarcoma: In osteosarcoma, we previously reported that anti-apoptotic Bcl-2 was directly targeted by miR-143, and miR-143 is downregulated in osteosarcoma and causes the upregulation of anti-apoptotic Bcl-2 [33].